Home » Bio
Long noncoding RNAs (lncRNAs) play a critical..
Amanda Hargrove, PhD:
Duke University
Mentors:
Hashim Al-Hashimi, PhD; Peter Dervan, PhD
Proposal Title:
Targeting the lncRNA SChLAP1 in Aggressive Prostate Cancer by the Assembly of Multivalent Small Molecule Inhibitor
Men with progressive metastatic prostate cancer are..
Justin Drake, PhD:
Rutgers University Cancer Institute of New Jersey
Mentor:
Robert DiPaola, MD
Proposal Title:
Elucidating Kinase Activation Pathways in Advanced Prostate Cancer
Dr. Sanda and his cross-disciplinary team of..
Martin Sanda, MD –:
Beth Israel Deaconess Medical Center
Nanoparticle-Targeted Peptide Vaccines for Prostate Cancer: The Harvard – Hopkins – Carolina Consortium
Co-Investigators:
Joseph M DeSimone, PhD; Simon M Arredouani, PhD; Charles Drake, MD, PhD
One of the causes for the initiation..
William G. Nelson, MD, PhD – :
Johns Hopkins Medicine
Induction of Synthetic Lethality with Epigenetic therapy (ISLET) for Systemic Treatment of Prostate Cancer
Co-Investigators:
Srinivasan Yegnasubramanian, MD, PhD; Jun O. Liu, PhD; Stephen B. Baylin, MD; Michael A. Carducci, MD; Martin J. Aryee, PhD
Despite initial response, most prostate cancers will..
Christopher J. Logothetis, MD –:
The University of Texas MD Anderson Cancer Center Mechanisms of Resistance to Androgen Biosynthesis Inhibition in Castration-Resistant Prostate Cancer Bone Metastases
Co-Investigators:
Gary Gallick, PhD; Sankar Maity, PhD; Randall Millikan, MD, PhD; Mark Bedford, PhD; Eleni Efstathiou, MD, PhD
Although family history is well-established as a..
Heather Cheng, MD, PhD:
University of Washington
Mentor:
Peter Nelson, MD
Proposal Title:
Identifying High-Penetrance Prostate Cancer Risk Genes: Leveraging Families for Next Generation Discovery and Prevention
As prostate cancer advances and spreads, it..
Dr. Glenn Liu, MD –:
UW Carbone Cancer Center Imaging Biomarkers of Treatment Response Using NaF PET/CT Imaging: a Prostate Cancer Clinical Trials Consortium (PCCTC) Effort
Co-Investigators:
Michael Morris; William Dahut, MD; Steven Larson, MD; Peter Choyke, MD; Robert Jeraj, PhD
Drs. Febbo and Higano propose a phase..
Philip G. Febbo, MD –:
University of California, San Francisco
Understanding the Clinical and Radiological Impact of XL184 through Treatment Science
Co-Investigators:
Celestia Higano, MD, Beatrice Knutson, PhD, Peter Nelson, MD, Edwin Posadas, MD, Ravi Salgia, MD, Evan Yu, MD
There are very few effective medications for..
Leland W.K . Chung, PhD –:
Cedars-Sinai Medical Center
Targeting Cell Death Programs in the Tumor and its Microenvironment
Co-Investigators:
Edwin Posadas, MD; Neil Bhowmick, PhD; Hyung L Kim, MD;
Andre Rogatko, PhD; Beatrice Knudsen, MD, PhD; Stuart Holden, MD; Mahul B. Amin, MD; Martin Gleave, MD; Michael Freeman, PhD; Daqing Wu, PhD; Matthew Bui, MD